DNase I hypersensitive sites (DHSs) are generic markers of regulatory DNA and harbor disease-and phenotypic trait-associated genetic variation. We established high-precision maps of DNase I hypersensitive sites from 733 human biosamples encompassing 439 cell and tissue types and states, and integrated these to precisely delineate and numerically index ~3.6 million DHSs encoded within the human genome, providing a common coordinate system for regulatory DNA. Here we show that the expansive scale of cell and tissue states sampled exposes an unprecedented degree of stereotyped actuation of large sets of elements, signaling the operation of distinct genome-scale regulatory programs. We show further that the complex actuation patterns of individual elements can be captured comprehensively by a simple regulatory vocabulary reflecting their dominant cellular manifestation. This vocabulary, in turn, enables comprehensive and quantitative regulatory annotation of both protein-coding genes and the vast array of well-defined but poorly-characterized non-coding RNA genes. Finally, we show that the combination of high-precision DHSs and regulatory vocabularies markedly concentrate disease-and trait-associated non-coding genetic signals both along the genome and across cellular compartments. Taken together, our results provide a common and extensible coordinate system and vocabulary for human regulatory DNA, and a new global perspective on the architecture of human gene regulation.
Introduction
A fundamental goal of the ENCODE project is to delineate with the highest possible precision the repertoire of regulatory DNA elements encoded within the human genome sequence. A canonical feature of actuated cis-regulatory elements -promoters, enhancers, silencers, chromatin insulators/enhancer blockers, and locus control regions -is focal alteration in chromatin structure resulting in heightened DNA accessibility to nucleases and other protein factors 1 . From their discovery 40 years ago 2 , DNase I hypersensitive sites (DHSs) have provided reliable signposts for high-precision regulatory DNA delineation in the human and other complex genomes 3 . DHSs typically mark compact (<250bp) elements densely populated by sequence-specific regulatory factors 4 ; these factors, in turn, produce nucleotide-resolution 'footprints' when exposed to DNase I 5 that further illuminate the underlying regulatory architecture and logic of regulatory DNA 6 .
During the past decade, the advent of genome-scale mapping of DHSs 7 and its application to diverse human and mouse cell and tissue types 8, 9 has yielded many insights into the organization, evolution 10 , activity 8 , and function 8, 11 of human regulatory DNA in both normal and malignant states 12 . Cell type-and state-selectivity of DNA accessibility is a cardinal property of regulatory DNA, with only a small fraction of all genome-encoded elements becoming actuated in a given cellular context 8, 12 . Most cell-selective behavior is manifested at distal, non-promoter elements, which comprise a plurality of DHSs 8 . Exceptions to this are the minority of DHSs that mark active or potentiated transcriptional start sites (TSSs), or those arising from non-promoter occupancy sites for CTCF 13 . While it is possible to infer functional properties of a subset of DHSs on the basis of surrounding histone modification patterns [14] [15] [16] , such features do not account well for complex behaviors such as primed elements poised to receive environmental or other stimuli 11 , or quiescent but developmentally important elements 12 .
The overwhelming majority of disease-and trait-associated variants identified by genome-wide association studies (GWAS) lie in non-coding regions of the genome, and are strongly enriched in DHSs 13, 17, 18 . Additionally, GWAS variants harbored within DHSs have been found to account for the majority of trait heritability explained by genotyped SNPs 19 . Beyond these general principles, which derive from simple localization of variants within DHSs, more comprehensive insights have been generally limited by the lack of DHS annotation.
The above insights have required the combination of data quality and biological breadth, enabling systematic recognition of cell-selective elements. As genome-scale data from diverse biological contexts have accumulated, systematic assessment of cell type-and state-selectivity has grown increasingly complex. It has become evident that large sets of widely distributed elements may exhibit common but complex patterns of cell-selective actuation 8 . However, the lack of a common coordinate system for DHSs has greatly hampered systematic identification and exploitation of these features.
Here we sought to expand a broad set of high-quality DHS maps, and to unify them into a common reference framework that both (i) incorporates precise genomic annotation that reflects observed biological variability in the pattern of DNA accessibility seen at individual elements, and (ii) captures complex cell-selective behaviors in a quantitative fashion. We show that the integration of DNA accessibility maps across large numbers of cell and tissue states results in a remarkably coherent framework with wide utility for annotation of the human regulatory DNA and gene landscapes; for defining how regulatory programs are encoded within the genome; and for clarifying links between genetic signals and genome-scale regulatory programs that enable new insights into the organization and interpretation of non-coding disease-and trait-associated variation.
A deep index of consensus human DHSs
To create deeply sampled reference maps of human regulatory DNA marked by DHSs, we performed DNase-seq 11 on a wide range of human cell and tissue samples spanning all major human organ systems ( Fig. 1a ; Methods ). Reference-grade data were created by rigorous quality screening for high signal-to-noise ratios and complex libraries ( Methods ), and were aggregated with prior high-quality data from the ENCODE 8 and Roadmap Epigenomics 20 Projects. We conservatively selected 733 biosamples with high-quality data, representing 439 cell or tissue types and states ( Fig. 1a; Supplementary Table 1 ; Methods ). The vast majority of these data derived from primary ex vivo cell and tissue samples (72% of samples) and from primary cells in culture (11%), with the remainder (17%) derived from immortalized cell lines. Collectively these data represent a >6-fold expansion of data sets and a >15-fold expansion of the number of biological contexts (i.e., different cell types or states) relative to the prior phase of ENCODE 8 .
A common coordinate system for accessible regulatory DNA
Deeply sampled reference maps of DHSs reveal rich and varied patterns of DNase I hypersensitivity ( Fig. 1b ). We sought to create a precise and durable reference framework for genomic elements that encode DHSs by (i) comprehensively and stringently (FDR 0.1%) delineating DHSs within each biosample using an improved algorithm ( https://github.com/Altius/hotspot2 ); (ii) systematically integrating individual biosample maps to define archetypal DHS-encoding elements; and (iii) assigning to each archetypal DHS element a unique numerical identifier, thus establishing a common coordinate system for regulatory DNA marked by DHSs ( Fig. 1c ).
We identified an average of 104,433 DHSs per biosample (collectively detecting 76,549,656 DHSs across all 733 biosamples). To define archetypal DHS-encoding elements, we developed a consensus approach outlined in Fig. 1c and Extended Data Fig. 1a-b . First, we aligned the summit coordinate (1bp) of each peak in DNase hypersensitivity signal across all biosamples to define the centroids of all spatially distinct DHSs. To resolve the boundaries of each element, we collated the local linear extent of DNase I hypersensitivity into a consensus range ( Methods ). We then combined centroids and boundaries into a single index of 3,591,898 distinct archetypal DHS-encoding sequence elements ( Supplementary Table 1 ) comprising, for each, (i) a consensus DHS summit; (ii) a 'core' region representing empirical confidence bounds on the centroid; and (iii) the consensus start and end coordinates of the archetypal DHS ( Fig.  1d, Extended Data Fig. 1c ). Because each DHS mapped within an individual biosample contributes to a single archetypal DHS in the consensus index, the provenance of each index DHS can be directly traced back to the DHSs of its contributing biosample(s). Finally, we assigned a unique identifier to each archetypal DHS within the index using a flexible and extensible numerical schema ( Fig. 1d ) that (i) conveys the genomic localization of each DHS; (ii) enables unlimited extension to newly-discovered DHSs; (iii) ensures compatibility with future reference genome builds and portability to personal genomes; and (iv) enables direct integration with DNase I footprints or other experimentally annotated components of a reference DHS ( Methods ). To create a robust framework for selecting more stringent genomic subsets of the complete index, we assigned confidence scores to all DHSs that reflect both the propensity for repeated observation in independent biosamples and the signal strength. These scores ( Extended Data Fig. 1d-e ) can be used to select DHS subsets at any desired level of stringency.
Consensus indexing enabled a far more precise and compact annotation of the accessible regulatory DNA compartment of the human genome than previously attainable 8 . The ~3.6 million index DHSs have an average width of 204bp (median 196bp, interquartile range 151-240bp) and annotate 665.57 Mb or 21.55% of the human genome sequence. DHS 'core' regions within the index have an average width of 55bp (median 38bp) and annotate 197.74Mb or 6.4% of the genome. DHS summits precisely define the peak in evolutionarily conserved nucleotides within DHSs, and the corresponding trough in the density of human genetic variation ( Extended Data Fig. 2e ). Most index DHSs localize distal to annotated Transcription Start Sites (TSSs; Extended Data Fig. 2 ). 53% lie within introns, ~3% within non-coding exons and UTRs, and ~2% are dually encoded within protein-coding exons ( Extended Data Fig. 2c ).
Cellular patterning of DNA accessibility
DHSs are extensively shared across individual biosamples and, more generally, across groups of biosamples from different human organ systems ( Fig. 1e and Extended Data Fig. 2f ). Previously we described the existence of stereotyped cross-cell-type actuation patterns shared by tens to hundreds of widely distributed DHSs sharing the same biological function such as enhancer activity 8 . We observed a high degree of complexity in the patterning of index DHS actuation across the 733 cell types and states studied ( Fig. 2a ), with both biologically modular and less structured patterns ( Fig. 2b ). Across this very large sample set, DHSs are infrequently selective for a single cell type or state, with complex mixing being the rule ( Fig. 1e , Extended Data Fig. 2f ).
In principle, the cross-cell-state actuation pattern of any given index DHS can be summarized by a limited number of biological 'components' combined in a weighted fashion; the same components can be used (orthogonally) to summarize the DHS repertoire of an individual biosample. A key advantage of this approach is the possibility to capture complex behaviors while maintaining the potential for biological interpretability, since DHS-centric information can inform biosamples and vice versa .
A compact vocabulary captures complex DHS regulatory patterns
To decompose the matrix of 3,591,898 DHSs x 733 biosamples we applied non-negative matrix factorization 21 (NMF; Extended Data Fig. 3a-c ), a technique initially employed in the field of computer vision to learn parts-based representations of objects, and semantic features of text 22 . We represented each DHS by a large enough number of components ( k =16) to ensure accuracy -i.e., the degree to which the original matrix can be reconstructed from the components -while retaining potential for interpretability via assignment of components to established biological contexts such as known cell lineage relationships, or cell states known to be specified by specific regulatory factors ( Fig. 2c, Extended Data Fig. 3d-f , Methods ).
To connect components with established biological contexts, we identified (i) the biosamples most strongly associated with each component, and (ii) the distribution of TF recognition sequences within DHSs most strongly associated with that component. For all components, the top 15 contributing cell or tissue samples were remarkably coherent, enabling provisional assignment of a meaningful biological label to most components ( Extended Data Fig. 4a ). Beyond these top associations, more general analyses further support these labelings ( Extended Data Fig. 4b-d , Methods ).
We next analyzed the distribution and enrichment of TF recognition sequences within DHSs most strongly associated with each component ( Extended Data Fig. 5a ; Methods ), revealing clear mappings between distinct sets of cell lineage-or state-specifying TFs and specific components ( Extended Data Fig. 5b ). Notably, these mappings are orthogonal to the biosample-to-component mappings described above. Finally, we combined biosample-to-component mappings and TF-to-component mappings to create a robust and biologically resonant regulatory 'vocabulary' that can be used to capture the actuation pattern of any DHS across cell types and states ( Fig. 2d, Box 1 ).
Biological annotation of DHSs using regulatory components
To date, over 99% of DHSs encoded by the human genome remain unannotated. Because the actuation pattern of each DHS across biosamples is captured by linear combinations of NMF components ( Fig. 2c, Extended Data Fig. 3c ), these combinations provide de facto annotations of the biological spectrum of every DHS ( Fig. 2e ). DHSs selective for a single cell type or state are annotated by a single majority component ( Fig. 2e , columns 1, 4, 5, 7, 8, 9) ; DHSs occurring in multiple cellular contexts are described by a combination of components ( Fig. 2e , columns 2,3,6,10); and constitutive DHSs are annotated by a rich mix of all components ( Fig. 2e , column 10), including a specific component that describes tissue-invariant behavior. In this schema, DHSs with similar cross biosample actuation patterns exhibit similar mixtures of components. For analytical practicality and visual compactness, the annotation of each DHS can be further summarized using its strongest single component ( Fig. 2e , bottom); we use this summary vocabulary for the analyses described below ( Supplementary Table 1 ).
Regulatory annotation of human genes
The function of many genes is closely connected with their regulation across cells and tissues, and hence with the activity spectra of their cognate regulatory elements. We observed that DHSs with similar annotations were highly clustered along the genome ( Methods ; Extended Data Fig. 6a-b ), particularly over gene bodies ( Extended Data Fig. 6c ). We thus reasoned that regulatory components of overlying DHSs could be utilized to annotate the likely functional compartments of their underlying genes. Quantifying the enrichment of congruently annotated DHSs around 56,832 GENCODE genes (protein-coding and non-coding) genome-wide revealed 20,658 genes (FDR 0.05) with significant clustering of DHSs belonging to the same component ( Fig. 3a-b ; Supplementary Table 2 ). This phenomenon was particularly striking for genes encoding tissue-regulatory factors such as GATA1 (erythroid/myeloid component DHSs), FOXP3 (lymphoid component), and HOXB9 (developmental component). A subset of genes showed enrichment of more than one component suggestive of different functions in different organ systems -for example CDX2 (embryonic/primitive and digestive components; Fig. 3c ).
Of 20,291 GENCODE protein coding genes, more than half (54.1%) could be assigned a regulatory component based on their overlying DHSs ( Fig. 3b ). To determine whether these assignments are concordant with their annotated function, we assessed (i) whether the most confidently annotated genes reflect their known function and (ii) whether genes annotated with a particular component are maximally expressed in cell types matching those components. The top genes annotated by the lymphoid component are all involved in immune response and disease ( Fig. 3e, Extended Data Fig. 7a ). Similar relationships were observed for other categories of genes including those annotated by the myeloid/erythroid component (erythropoiesis or hematopoietic stem cell genes, Fig. 3e, Extended Data Fig. 7b ), a stromal component (collagen genes and fibronectin, Fig. 3e, Extended Data Fig. 7c ) , and the tissue-invariant component (housekeeping genes, Fig. 3e, Extended Data Fig. 7d ). This phenomenon was particularly striking for TF-encoding genes 4 such as lineage specifying master regulators for cardiac development (cardiac component, Fig. 3f, Extended Data Fig. 8b ) or development of other organ systems ( Extended Data Fig. 8 ).
To explore the concordance between regulatory vocabulary annotations and gene expression across cell types and states, we interrogated a compendium of over 100,000 uniformly processed RNA-seq data sets 23 . After matching vocabulary components with tissue-relevant expression data sets ( Methods ), we observed strong correspondence between the vocabulary-based annotation of genes and the cell or tissue types in which they were maximally expressed ( Fig. 3g ).
Annotation of genes with unknown functions
Despite intensive study, the function of many human genes remains obscure, particularly those with lowly or seemingly erratic expression patterns -for example, zinc-finger (ZNF) TFs 4,24 or long non-coding RNA genes 25 . Nearly half of ZNF TFs (43.7%) could be annotated with a single regulatory component ( Extended Data Fig. 9a ) thus indicating their likely target biological sphere of activity. 38.7% of long non-coding genes evinced clear mappings to regulatory components ( Extended Data Fig. 9b ), as did 18% of pseudo-genes 26 ( Extended Data Fig. 9c ), possibly reflective of remnants of regulatory states prior to ancient gene duplications. Beyond genes, we reasoned that entire pathways could be annotated using the overlying DHS landscapes of their constituent genes ( Extended Data Fig. 10a ) -for instance, the KEGG pathway 'Allograft rejection' is strongly enriched for the lymphoid component ( Extended Data Fig. 10b ), consistent with the principle that genes involved in similar biological processes share similar patterns of regulatory element actuation.
Annotation of trait-associated genetic variation
We next asked whether DHS annotations could expand insights into the role(s) of genetic variation harbored within regulatory DNA, and provide a more meaningful framework for interpreting the pathophysiological basis of disease and trait associations. A rank-based analysis of disease/trait versus regulatory component associations (explicitly controlling for large scale Linkage Disequilibrium (LD) structure; Methods ) revealed increasingly strong component-specific enrichments of association signals across diverse traits ( Fig. 4a, Extended  Data Fig. 11a,b) . Notably, the observed enrichments could not typically be obtained by considering only DHSs from biosamples most closely related to the relevant regulatory component (e.g., lymphoid cell biosamples vs. lymphoid component; Fig. 4a, Extended Data  Figs. 4a, 11c ).
Quantifying the extent to which DHS annotations captured SNP-based trait heritability (h g 2 , Fig.  4b , white bars) revealed a strong increase in heritability enrichment for trait-relevant vocabulary components relative to index DHSs ( Fig. 4b , colored bars vs. grey bars, respectively). Heritability was markedly enriched specifically within DHS 'core' regions, providing orthogonal evidence supporting the delineation and importance of these subregions ( Fig. 4b ).
To generalize these observations, we compiled >1,300 traits with positive estimated SNP-based heritability from the UK Biobank project 27 and from curated published data 28 . Of these, 261 diseases and traits showed highly significant component-specific enrichment in heritability, particularly for pathophysiologically relevant regulatory components ( Fig. 4c, Extended Data  Fig. 12a , FDR 1%). Restricting DHS delineations to 'core' regions again yielded consistently higher levels of enrichment compared to full DHSs ( Extended Data Fig. 12b-c ).To remove potentially confounding contributions from multiple genomic annotations overlapping the same SNP, we quantified the statistical significance of DHS component heritability contributions while controlling for the contribution of all other annotations ( Methods ). For virtually all reported traits, DHS component annotations significantly (p < 0.01) captured SNP-based trait heritability ( Fig.  4d , black line).
To quantify the concentration of trait-associated genetic signal in DHSs annotated by specific regulatory components relative to the full repertoire of DHSs in disease/trait-relevant cell types we performed cell type-specific heritability analyses 29 ( Methods ). Component-annotated DHSs offer a significant improvement in capturing trait heritability compared to individual datasets (p < 2.2 x 10 -16 ; Fig. 4d , grey solid line). Strikingly, we find that at the level of individual traits, in 68 out of 261 (26%) cases DHS component annotations better capture trait heritability than individual DNase-seq datasets ( Fig. 4e ).
Concentration of trait-associated variation in component-annotated gene body DHSs
The clustering of concordantly regulated DHSs within gene bodies ( Fig. 3 ) prompted us to speculate that such DHSs were more likely to contain relevant genetic signals. To test this, we quantified the significance of DHS component heritability separately for concordant (17% of DHSs) and discordant (34%) DHS annotations ( Fig. 4f ). Although in the minority, the former uniquely and strongly contributed to SNP-based trait heritability relative to DHSs occurring in the same genes but discordant with the gene's component labeling. DHSs proximal to genes not labelled by any DHS component provide the weakest heritability contributions, while intergenic DHSs contribute modestly ( Fig. 4f, Extended Data Fig. 12d ).
Taken together, our results show that partitioning the trait heritability encoded in DHSs based on regulatory components provides a novel and powerful approach for prioritization of genetic signals.
Discussion
Focal chromatin accessibility triggered by sequence-specific regulatory factors is the cardinal feature of active regulatory elements encoded in mammalian genomes, underpinning the discovery of all currently defined classes of transcriptional control elements in the human genome 8 . Here we have presented by far the most comprehensive and precise map of DHSs (and hence of regulatory DNA thus marked), and the first universal annotation of DHSs that captures their complex actuation patterns across diverse cell types and states. Both the unprecedented precision of annotation and the increased richness with which cell state-variable behaviors could be captured and resolved to individual DHSs were enabled by jointly analyzing high-quality data across hundreds of wide-ranging biological contexts, and thus unattainable from smaller scale or individual data set-focused analyses.
We have leveraged the high positional stability of DHS summits across cell types and states (median 38bp across >700 cell contexts) to define and annotate archetypal DHS-encoding elements within the human genome, and to encompass these under a common coordinate system and nomenclature. DHS identifiers are robust to genome builds, and transferable to personal genomes and emerging graph-based approaches to genome analysis 30, 31 . They also enable straightforward incorporation of cell-selectivity properties (e.g., regulatory components) and structural/functional features such as DNase footprints. Because DHS summits represent local maxima in evolutionarily conserved nucleotides, TF motif density, and enrichment for both GWAS variants generally and for variants that account for trait heritability, the index of archetypal DHSs adds a unifying axis to diverse analyses, from regulation to genetics.
The DHS landscape can be viewed as an integrative readout of the interaction of a complex milieu of trans-acting regulatory factors with DNA and chromatin. Shifts in this milieu under different cell environments result in the selective appearance/disappearance of DHSs from one cell context to another, and forms the foundation of regulatory components. We have used these components to provide the first universal annotation of human DHSs, encompassing both the dominant component for each element and the spectrum of contributing components. The latter provides a regulatory 'barcode' that captures the complex 'on/off' behavior of a given element across cell types and states. Because each regulatory component can be mapped to a set of contributing TFs, component barcodes provide a gateway for mechanistic insights into regulatory pathways and networks.
These new DHS annotations thus greatly expand the analytical horizon beyond cell/tissue-agnostic annotations such as chromatin states 13, 32 .
DHSs from the same regulatory component are highly clustered within gene bodies, and we have taken advantage of this feature to create gene-centric annotations reflecting the dominant regulatory programs of ~54% of protein-coding (10,979 genes) and ~38% of long non-coding RNA genes (5,682 genes). For protein-coding genes, these annotations are distinct from yet highly complementary to existing annotations based on structural and biological pathway features or gene expression alone 23, 33, 34 . For non-coding RNA genes, regulatory program annotations provide a new window on possible biological functions. Because regulatory components can be resolved to coherent transcription factor programs, gene-centric regulatory annotations should provide a new window into regulatory network analyses 35 , and should also enable systematic incorporation of non-coding RNA genes in parallel with protein-coding genes.
Our results indicate that regulatory components can significantly clarify non-coding genetic signals. Using DHS indexing and regulatory components, it is now possible to triangulate the genetics-gene regulation interface on three axes: (i) a genomic position axis, which has now been finely resolved to consensus DHS summits; (ii) a cell/tissue biological axis captured in regulatory components; and (iii) a gene context axis reflecting the coherent co-localization of similarly regulated DHSs over gene bodies. The concentration of trait heritability within highly compact ~50bp DHS summits -even relative to the immediately adjacent DHS 'arms' -is particularly striking given the trough in the density of overall human variation at DHS summits ( Extended Data Fig. 2e ), and likely reflects the concentration of disease/trait-associated variants within transcription factor footprints (see accompanying manuscript by Vierstra et al. ) , which are most dense within DHS summits. On the cell/tissue biological axis, regulatory components now provide a systematic and principled approach for combining the complex biological landscapes of individual cell types, resulting in a more powerful and comprehensive framework for analyzing the intersection of cell/tissue selectivity and trait heritability than could be achieved with individual biosamples or simple combinations thereof. Finally, on the gene axis, the concentration of GWAS variants within DHSs of a gene's dominant component reinforces the biological coherence of these elements and provides a new pathway for separating variants implicating a given gene from those within its body or flanking regions that are connected with nearby or distant genes.
On a broader level, the DHS index and component framework we report represents a transition from an exploratory era focused on discovery of novel elements, to a map-centric framework focused on detection of an annotated element within a particular biological context. This framework should prove particularly valuable for anchoring single cell studies, which are presently at least 1000-fold too sparse for robust delineation of DHSs within single cells. The index/component framework is highly information rich, and provides an inter-operable reference for annotating functional connections between elements and genes or other elements, and for functional categorization of elements -two intertwined challenges that represent the next frontier in human genome annotation.
Box 1: DHS vocabulary component labeling
◼ Placental/trophoblast -Placenta and trophoblast biosamples. Strong enrichment for binding sites of GCM1, selectively expressed in trophoblasts and placenta in general 36 and associated with pre-eclampsia in pregnant women 37 . ◼ Primitive/embryonic -Embryonic stem cell and related biosamples. Most enriched motif is that for POU5F1/OCT4, reflecting its key role in embryonic development and pluripotency. ◼ Organ development/renal -Largely captures fetal kidney biosamples, with strong enrichment for development-related Homeobox protein (HOX) factors, as well as PAX2, associated with early kidney development 38 . ◼ Pulmonary development -Consists of fetal lung biosamples. Enriched for CEBPB and FOXC2 motifs, the latter of which is implicated in lung development and maturation 39 . ◼ Lymphoid -T-cells and other immune-related cellular conditions. Its most enriched motifs are Interferon-Regulatory Factors (IRF4, IRF1, IRF5, etcetera), in line with their critical role in the (adaptive) immune system 40 . ◼ Myeloid/erythroid -CD34+ cells and shows strong motif enrichments for not only ETS/SPI1, but also for GATA1by itself, as well together with TAL1. ◼ Cardiac -Associated with heart-related biosamples. Strongly enriched for motifs of the Myocyte enhancer factor-2 (MEF2) transcription factor, a core cardiac transcription factor 41 . ◼ Musculoskeletal -Associated with muscle(-related) and bone biosamples. Enriched for Musculin (MSC) motifs, with known key roles in regulating myogenesis. ◼ Vascular/endothelial -Consists mostly of HMVEC cells and is enriched for motifs of ERG, a member of the erythroblast transformation-specific (ETS) family of transcription factors, required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. ◼ Neural -Brain and other nervous system biosamples. General enrichment for AT-rich homeobox motifs, as well as many highly specific NEUROD2 motifs. ◼ Digestive -Associated with intestine, liver and bowel mucosa biosamples. Strong enrichment for motifs of hepatocyte nuclear factor 4 (HNF4), critical for liver development. ◼ Renal/cancer -Mostly adult kidney biosamples, including renal cancer. Enriched for HNF1B, the HNF1A paralog involved in kidney function. ◼ Cancer/epithelial -Associates with various cancer types, as well as general epithelia. The top-scoring motif is for p53 (cancer-related) and p63, which has been proposed to play a dual role 42 : initiating epithelial stratification during development and maintaining proliferative potential of basal keratinocytes in mature epidermis. ◼ Stromal A -Captures fibroblast biosamples. Enriched for motifs of Jun dimerization protein 2 (JDP2), as well as other components of the AP-1 transcription factor (JUN, FOS). This is in line with the roles of these factors in ultra-violet radiation response 43 . ◼ Stromal B -Captures similar Biology as the Stromal A component. ◼ Tissue invariant -Lacks strong association with specific cell and tissue types, but shows enrichment for a diverse set of housekeeping factor motifs, such as CTCF, ETS and NRF. Trophoblast  Trophoblast  fPlacenta  Trophoblast  fPlacenta  fPlacenta  fPlacenta  fPlacenta  fPlacenta  fPlacenta  fPlacenta  Trophoblast  Trophoblast  fPlacenta  fPlacenta  Trophoblast  Trophoblast  fPlacenta  Dendritic_cells_C190  CD4  CD4  Oci_Ly_7  Karpas_422  Namalwa + Sendai virus_2h  Namalwa_0  Namalwa + Sendai virus_2h  Jurkat  Jurkat  RPMI_8226  RPMI_8226  hTH2  CD20  CD19  MM_1S  h T R  fSpleen  Karpas_422  fLiver  fThymus  Oci_Ly_7  GM12865  CD8  hTH2  GM06990  iTH1  hTH1  hTH1  CD4  CD4  GM12864  hTH17  GM12878  GM12878  hTH1  GM12865  fThymus  fThymus  CD8  GM06990  CD8  CD3  CD56  fThymus  fThymus  fThymus  CD3  iTH2  CD20  CD3  CD19  CD8  CD4  CD19  CD4  fThymus  CD3  fThymus  CD56  CD4pos_N  Dendritic_cells_C51  CD14  CD14  CD34_T18  KBM7  KBM7  CD34  CD34  CD34  CD34  CMK  CD34_T0  CD34_T17  CD34_T17  CD34_T15  CD34  CD34  CD34  CD34  NB4  CD34  CD34  HL60  HL60  CD34  CD34  NB4  CD34_T0  CD34  CD34  CD34  CD34  CD34_T6  CD34_T6  CD34_T8  CD34_T8  CD34_T8  K562  K562  K562  K562  CD14  CD14  CD34  K562  CD34_T4  CD34_T4  fLeftVentricle  fLeftVentricle  fHeart  fLeftVentricle  fRightVentricle  fHeart  fUmbilical_cord  fHeart  fHeart  fHeart  fAdrenal  fAdrenal  fHeart  fHeart  RuES2_cms  H7_hESC_T14  RuES2_cms  H7_hESC_T14  Heart  fHeart  fHeart  fTestes  fLeftAtrium  fHeart  fHeart  fHeart  fHeart  fHeart  fHeart  fHeart  fHeart  fHeart  fMuscle_arm  fMuscle_lower_limb  fMuscle_back  fMuscle_trunk  fMuscle_back  fBone_arm_right  fBone_arm_left  fTongue  fTongue  fMuscle_trunk  fMuscle_leg  SJCRH30  SJCRH30  fTongue  fMuscle_back  Psoas_Muscle  fMuscle_back  fMuscle_leg  fMuscle_back  fMuscle_arm  fMuscle_upper_limb_sk  fMuscle_arm  fMuscle_leg  fMuscle_arm  fBone_femur  fBone_leg_right  fBone_leg_left  fMuscle_back  fMuscle_leg  fMuscle_arm  fMuscle_leg  fMuscle_back  fMuscle_arm  fMuscle_leg  fMuscle_back  fMuscle_leg  fMuscle_back  fMuscle_arm  fMuscle_arm  fMuscle_leg  fMuscle_upper_back  fMuscle_leg  fMuscle_back  fMuscle_leg  fMuscle_arm  fMuscle_arm  fMuscle_arm  fMuscle_back  fMuscle_arm  fMuscle_arm  fMuscle_leg  fMuscle_back  fMuscle_leg  fMuscle_back  fMuscle_arm  fMuscle_leg  fMuscle_arm  fMuscle_back  fMuscle_arm  fMuscle_trunk 
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